No profile data available.
ImageneBio, Inc. (IMA) is a healthcare company, based in San Diego, United States.
It reported revenue of $3.50 million for fiscal year 2024, down 56.0% from fiscal year 2023, and net income of -$36.57 million. Its market capitalization was $75.81 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
ImageneBio reported $3.50 million in revenue for fiscal year 2024, down 56.0% from $7.96 million in fiscal year 2023.
$75.81 million as of December 4, 2025.